logo
Using the International Gaucher Disease Registry data: Can we devise a virtuous circle for treated patients?
A benchmark analysis of the achievement of therapeutic goals for type 1 Gaucher disease patients treated with imiglucerase
Life expectancy in Gaucher disease type 1
The spectrum of adult B-lymphoid leukemias with BCR-ABL: Molecular diagnostic, cytogenetic, and clinical laboratory perspectives
Comparison of red blood cell hematology among normal, α-thalassemia-1 trait, and hemoglobin Bart’s fetuses at mid-pregnancy
Effect of prophylactic cyclosporine therapy on ADAMTS13 biomarkers in patients with idiopathic thrombotic thrombocytopenic purpura
Factor XI gene mutations in factor XI deficient patients of the Czech Republic
Cyclic neutropenia in mammals
Expansion of hematopoietic stem/progenitor cells
Pencil cells and prekeratocytes in iron deficiency anemia
Laboratory testing for fibrinogen abnormalities
Acquired iron overload associated with antitransferrin monoclonal immunoglobulin: a case report
Flowers in a bone marrow aspiration
A case report of secondary autograft failure due to Gaucher disease
Therapy-related leukemia in patients with human immunodeficiency virus infection after treatment for non-Hodgkin lymphoma
Combination of rituximab and chemotherapy showing anti-tumor effect in gamma heavy chain disease expressing CD20
Treatment of invasive aspergillosis with nonmyeloablative allogeneic stem cell transplantation: The hunter becomes the hunted
AN APPROACH FOR THE DEVELOPMENT OF REFERENCE INTERVALS FOR PLATELET AGGREGATION TESTING
ARE CLINICAL LABORATORIES FOLLOWING ISTH RECOMMENDATIONS FOR LUPUS ANTICOAGULANT TESTING? RESULTS OF A 2ND NASCOLA SURVEY
A PLATE BASED PLASMA VON WILLEBRAND FACTOR (VWF):RISTOCETIN COFACTOR ACTIVITY ASSAY
NASCOLA EQA PROGRAM: A REVIEW OF ANTITHROMBIN ACTIVITY AND ANTIGEN SURVEY RESULTS FROM 2002 TO 2005
EVALUATION OF PLATELET AGGREGATION RESPONSES IN SAMPLES WITH REDUCED PLATELET COUNTS
THE EFFECT OF DIFFERENT SAMPLE TYPES ON COAGULATION LABORATORY TESTS
INFLUENCE OF SPECIFIC ANTIBODY, NORMAL POOL, AND DETECTION METHODOLOGY ON VON WILLEBRAND FACTOR (VWF) MULTIMER ANALYSIS
EFFECTS OF HEPARIN ON FACTOR VIII INHIBITOR SCREENING AND TITERING ASSAYS
INACCURACY OF POINT-OF-CARE (POC) WHOLE BLOOD INR COMPARED TO VENOUS PLASMA INR AT HIGH INR VALUES
EVALUATING AND MANAGING LABORATORY TESTING QUALITY
TEST VALIDATION PROCESSES AND CRITERIA
ANALYTICAL SPECIFICATIONS FOR HAEMOSTASIS ASSAYS
PROFICIENCY TESTING: HOW TO USE RESULTS FOR MONITORING AND IMPROVING COAGULATION TEST QUALITY
NASCOLA 1997-2007: LOOKING BACK AND FORWARD
ECAT: FROM ANALYTICAL PERFORMANCE TOWARDS DIAGNOSTIC PERFORMANCE
COLLEGE OF AMERICAN PATHOLOGISTS COAGULATION RESOURCE COMMITTEE: IMPROVING LABORATORY PRACTICES
EQATH - A NEW INTERNATIONAL COLLABORATIVE INITIATIVE FOR THROMBOSIS AND HEMOSTASIS LABORATORY TESTING QUALITY
PLATELET FUNCTIONAL DISORDERS AND TESTING
EVALUATING AND SELECTING A COAGULATION ANALYZER
LUPUS ANTICOAGULANT (LA) TESTING AND INTERPRETIVE REPORTING
THE NASCOLA/ECAT LUPUS ANTICOAGULANT (LA) AND ANTIPHOSPHOLIPID ANTIBODY (APL) TESTING PRACTICES QUESTIONNAIRE
ECAT LA TESTING RESULTS AND PRACTICE IMPLICATIONS
LABORATORY TESTING FOR TTP: ADAMTS-13 ACTIVITY AND ANTIGEN ASSAYS
“OH, YOU HAVE BLOOD GROUP O”: DIAGNOSTIC TESTING IMPLICATIONS OF THE NHLBI VWD GUIDELINES FOR DIAGNOSIS AND MANAGEMENT (2007)
THROMBOPHILIA TESTING: ISSUES AND RECOMMENDATIONS